ReviewClinical science (London, England : 1979)2026
Burn-associated metabolic dysfunction: could extracellular vesicles play a role?
Review in Clinical science (London, England : 1979), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hypermetabolism is a well-recognized component of the detrimental systemic response following severe burn injury. Despite extensive clinical observations and research output, the underlying mechanisms that drive this persistent metabolic dysregulation remain poorly understood. One emerging area of interest is the role of extracellular vesicles (EVs), small membrane-bound particles released by cells that are increasingly recognized as important mediators of intercellular communication and contributors to various pathological conditions. Recent studies have highlighted their significant involvement in metabolic regulation, acting as carriers of bioactive molecules that influence metabolic pathways in recipient cells. EVs contribute to the modulation of glucose and lipid metabolism, insulin sensitivity, mitochondrial function, and inflammation, thereby influencing systemic metabolic homeostasis. In this context, EVs have been proposed as potential mediators in the metabolic problems that follow severe burn injuries. Burn-induced hypermetabolism, marked by insulin resistance, muscle wasting, and systemic inflammation, is affected by exosome-driven signaling between damaged tissues and metabolic organs. Exosomes released after a burn carry inflammatory cytokines, stress-response proteins, and metabolic regulators that change cellular functions in distant organs such as the liver, skeletal muscle, and adipose tissue. Understanding how exosomal communication contributes to post-burn metabolic issues could lead to new diagnostic and treatment options for improving recovery and metabolic health in burn patients. This review aims to clarify the role of EVs in burn-induced metabolic problems, emphasizing their potential as new mediators in the complex systemic response, which may provide new insights into the underlying mechanisms and help identify novel therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.